{
  "schemaVersion": "deck-intelligence.v1",
  "id": "019de074-7472-72bc-8651-e49cc0d0319c",
  "slug": "c2a880ad0c526527fe8aa49c40270224",
  "title": "Arbutus Biopharma | Investor Presentation Deck | 28 slides",
  "subtitle": "Arbutus Biopharma · 2023-03",
  "author": "Arbutus Biopharma",
  "date": "2023-03-01 00:00:00",
  "pageCount": 28,
  "kind": "pitchdeck",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "document": {
    "id": "019de074-7472-72bc-8651-e49cc0d0319c",
    "slug": "c2a880ad0c526527fe8aa49c40270224",
    "title": "Arbutus Biopharma | Investor Presentation Deck | 28 slides",
    "rawTitle": "Arbutus Biopharma | Investor Presentation Deck | 28 slides",
    "authorId": "arbutus-biopharma",
    "authorName": "Arbutus Biopharma",
    "authorDisplay": "Arbutus Biopharma",
    "kind": {
      "slug": "pitchdeck",
      "label": "Pitch deck"
    },
    "sourceType": {
      "slug": "investor_relations",
      "label": "Investor relations"
    },
    "fileName": "2023-03__arbutus-biopharma__investor-pres__c2a880ad.pdf",
    "sourceUrl": "https://www.slidebook.io/company/arbutus-biopharma/presentation/c2a880ad0c526527fe8aa49c40270224/",
    "sourceDate": "2023-03-02 00:00:00",
    "presentationDate": "2023-03-01 00:00:00",
    "ingestedAt": "2026-04-30 22:13:41.719868+00",
    "status": "ready",
    "pageCount": 28,
    "orientation": "landscape",
    "aspectRatio": 1.7777778,
    "targetCompany": null,
    "targetTicker": null,
    "metadata": {
      "corpus": "slidebook",
      "industry": "biotechnology",
      "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2023-03__arbutus-biopharma__investor-pres__c2a880ad",
      "image_width": 1920,
      "image_format": "jpg",
      "deck_type_raw": "Investor Presentation Deck",
      "deck_type_slug": null,
      "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/"
    }
  },
  "coverage": {
    "pageCount": 28,
    "pagesIndexed": 28,
    "pagesWithImages": 28,
    "pagesWithMetadata": 28,
    "imageCoveragePct": 100,
    "metadataCoveragePct": 100,
    "componentCount": 141,
    "chartCount": 11,
    "metricSlides": 0,
    "toolMatches": 23,
    "documentToolMatches": 0,
    "frameworkMatches": 5,
    "arcMatches": 1,
    "beatMatches": 5,
    "loopMatches": 2,
    "patternMatches": 0,
    "storymakersMatch": false,
    "scoreAvailable": false,
    "reviewAvailable": false,
    "activistThesisAvailable": false,
    "pitchdeckMetadataAvailable": false,
    "pitchdeckProfileAvailable": false
  },
  "blocks": [],
  "matches": {
    "arcs": [
      {
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
        "evidence": "The document follows a clear problem-agitate-solution structure, highlighting the unmet medical need, the limitations of current treatments, and the potential of Arbutus Biopharma's pipeline.",
        "isPrimary": true,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 03:25:42.002717+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "beats": [
      {
        "to": 7,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 6,
        "name": "Problem",
        "beatId": "9efdc5e5-038d-4e00-a590-e4a91a4f4a25",
        "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
        "beatType": {
          "name": "Problem (Identify pain)",
          "slug": "problem-agitate-solution-problem-identify-pain",
          "status": "active",
          "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131",
          "version": 1,
          "description": null
        },
        "evidence": "The document identifies HBV as a significant unmet medical need (p6-7).",
        "position": 0,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Complication",
          "slug": "complication",
          "status": "active",
          "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
          "version": 1,
          "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 7,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 7,
        "name": "Complication",
        "beatId": "bc9bddc7-5053-4090-b64a-3a6d7a5459d0",
        "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
        "beatType": {
          "name": "Agitate (Make it worse)",
          "slug": "problem-agitate-solution-agitate-make-it-worse",
          "status": "active",
          "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456",
          "version": 1,
          "description": null
        },
        "evidence": "The document highlights the limitations of current treatments (p7).",
        "position": 1,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Development",
          "slug": "development",
          "status": "active",
          "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
          "version": 1,
          "description": "The middle stretch in arcs that have one. Often where length problems creep in."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 28,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 8,
        "name": "Solution",
        "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
        "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
        "beatType": {
          "name": "Solution (Provide relief)",
          "slug": "problem-agitate-solution-solution-provide-relief",
          "status": "active",
          "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
          "version": 1,
          "description": null
        },
        "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
        "position": 2,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Resolution",
          "slug": "resolution",
          "status": "active",
          "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
          "version": 1,
          "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 14,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 10,
        "name": "Evidence & Proof",
        "beatId": "5dda647e-e3c1-4360-9757-fc347cc61491",
        "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
        "beatType": {
          "name": "Evidence & Proof",
          "slug": "consultants-gambit-evidence-proof",
          "status": "active",
          "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a",
          "version": 1,
          "description": null
        },
        "evidence": "The document presents data and results from clinical trials, including AB-729-001 (p10-14).",
        "position": 3,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Evidence",
          "slug": "evidence",
          "status": "active",
          "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
          "version": 1,
          "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 28,
        "arc": {
          "name": "Problem-Agitate-Solution",
          "slug": "problem-agitate-solution",
          "status": "active",
          "bestFor": "Sales pitches, urgency-driven, competitive displacement",
          "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 17,
        "name": "Impact & Next Steps",
        "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
        "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
        "beatType": {
          "name": "Impact & Next Steps",
          "slug": "consultants-gambit-impact-next-steps",
          "status": "active",
          "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
          "version": 1,
          "description": null
        },
        "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
        "position": 4,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Resolution",
          "slug": "resolution",
          "status": "active",
          "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
          "version": 1,
          "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      }
    ],
    "loops": [
      {
        "to": 8,
        "from": 7,
        "loop": {
          "name": "27_cost_of_inaction",
          "slug": "27-cost-of-inaction",
          "status": "active",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "description": "Quantify what happens if the audience does nothing",
          "familyLabel": null,
          "categoryName": "Urgency",
          "categorySlug": "urgency"
        },
        "matchId": "b3e8d7b9-0084-4114-a08f-62c827296b2f",
        "evidence": "The document highlights the unmet medical need and the limitations of current treatments (p7-8).",
        "position": 0,
        "objective": "What is the cost of not addressing HBV?",
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:25:42.213917+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      },
      {
        "to": 22,
        "from": 20,
        "loop": {
          "name": "53_jobs_to_be_done",
          "slug": "53-jobs-to-be-done",
          "status": "active",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "canonId": "019dd956-7b6c-7594-b5b3-eecbe0ab48e8",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying",
          "familyLabel": null,
          "categoryName": "Consulting Framework",
          "categorySlug": "consulting-framework"
        },
        "matchId": "660159c2-70d4-4fb9-adcd-06670ff0292c",
        "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-101 and AB-161, as potential solutions (p20-22).",
        "position": 1,
        "objective": "What are the key challenges in treating HBV?",
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-17 03:25:42.249373+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "tools": [
      {
        "tool": {
          "name": "Slide recipe: Cover",
          "slug": "cover-slide",
          "status": "active",
          "bestFor": null,
          "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3",
          "version": 1,
          "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65",
          "description": "The first ten seconds. Build it deliberately.",
          "familyLabel": "slide-recipe",
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "designer",
        "layer": "slide",
        "agents": [
          "designer"
        ],
        "matchId": "2ff07bb0-e0a5-44b7-a469-ca198aa6851e",
        "evidence": "title/headline: Corporate Presentation",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:20:05.618074+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 1,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Executive summary",
          "slug": "executive-summary",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
          "version": 1,
          "bodyDocId": null,
          "description": "A condensed view of the entire argument on a single slide / block.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "d033ce20-6bdc-4f07-a572-a229cb029268",
        "evidence": "list/bullet: Indications with significant unmet medical need; Team with virology expertise; Broad portfolio; Lead HBV compound AB-729; Strong financial position; Patented LNP technology",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:20:05.781946+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 4,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Gantt chart",
          "slug": "gantt-chart",
          "status": "active",
          "bestFor": null,
          "canonId": "019de52d-1fa2-7206-bb14-bb9ff5fccdba",
          "version": 1,
          "bodyDocId": null,
          "description": null,
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "04de32d1-7e2c-435a-9288-664b702ab7d4",
        "evidence": "chart/gantt-chart: Pipeline status chart",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:20:06.368916+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 5,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "fc9395ba-5e9a-4b0a-b66f-ac004b6642d9",
        "evidence": "list/bullet: Cause & Symptoms: Life-threatening liver infection, transmission, chronic infection risks.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:06.439058+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 6,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Problem Statement Canvas",
          "slug": "problem-statement-canvas",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18",
          "version": 1,
          "bodyDocId": null,
          "description": "Structured definition of the problem: What? Who? Where? When? Scale?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Architect",
        "layer": "slide",
        "agents": [
          "Architect"
        ],
        "matchId": "897a0716-6e77-49e3-9d30-eab8d1c1555a",
        "evidence": "type: problem_statement",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:20:06.509922+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 7,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "0e52eddb-9285-4afe-92f0-bc6c95b0e185",
        "evidence": "list/bullet: Suppress HBV DNA; Reduce viral antigens; Boost host immune response",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:06.579903+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 8,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Process flow",
          "slug": "process-flow",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4dca-76bc-8135-401836a1c4c0",
          "version": 1,
          "bodyDocId": null,
          "description": "Workflow, steps, sequential diagram.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "0367a621-df45-4dc4-805d-c84935c17b75",
        "evidence": "diagram/process: Suppress, Reduce, Boost process flow",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:20:06.614305+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 8,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "26cf00af-3af8-4e18-b6cc-a60ec584b746",
        "evidence": "list/bullet: Single trigger RNAi agent targeting all HBV transcripts; Inhibits HBV replication and lowers all HBV antigens; Pan-genotypic activity; Demonstrated complementarity; Actively targets liver; Active against ccc",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:06.683309+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 9,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "c280fa0a-28a7-4628-a36d-e5e57d7d2b94",
        "evidence": "list/bullet: Robust HBsAg declines across all cohorts",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:06.753405+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 10,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Table data",
          "slug": "table-data",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
          "version": 1,
          "bodyDocId": null,
          "description": "Tabular layouts of structured data.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "5eb7fcf4-2d60-46eb-a50c-4fd26acca928",
        "evidence": "table/data: Mean (SE) Baseline and Δ log10 HBsAg by Visit table",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:20:06.823713+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 11,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "2d76ca3b-ed5f-46a6-93ea-5486e2d94cc2",
        "evidence": "list/bullet: AB-729 is generally safe and well-tolerated after repeat dosing for up to 48 weeks; No treatment-related SAEs or discontinuations due to AEs; No treatment-related Grade 3 or 4 AEs; No treatment-related Grade",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:07.006891+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 15,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "a326158e-ef83-481a-a7e2-05759d5caa8d",
        "evidence": "list/bullet: AB-729 provided robust and comparable HBsAg declines regardless of dose, dosing interval, HBeAg or DNA status. ~75% (26 of 34) patients had HBsAg levels <100 at some point. 50% (16 of 32) maintained HBsAg <1",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:07.079981+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 16,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Table data",
          "slug": "table-data",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
          "version": 1,
          "bodyDocId": null,
          "description": "Tabular layouts of structured data.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "f7354edc-2ea5-44e4-8f46-aed0bb8f76ce",
        "evidence": "table/data: Deal economics for Arbutus: $40M Upfront payment; $15M Equity investment; Up to $245M Commercialization and milestone payments; Double-digit up to low twenties % Tiered royalties",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:20:06.989848+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 19,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "ce54379f-7896-4d37-81b2-c789a220c127",
        "evidence": "list/bullet: AB-101: Blocks PD-L1/PD-1 interaction; Activates HBV-specific immune responses; Novel MOA identified; Demonstrates robust checkpoint mediated in vivo effect; Improves HBV-specific T- and B-cell responses.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:07.07211+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 20,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "403fd3a1-f37e-42e7-9504-c7a8a1bca350",
        "evidence": "chart/line: AB-101 reduces PD-L1 on the surface of human primary myeloid cells",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:20:07.155119+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 21,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "8a118b57-f7d0-4710-9399-b5384e823ce2",
        "evidence": "chart/bar-vertical: AB-101 reinvigorates HBV-specific cHBV patient T-cells",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:20:07.195669+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 21,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "aee335de-f830-483d-9ee2-0cd83c89e8da",
        "evidence": "list/bullet: Safety: Next generation small molecule anticipated to circumvent non-clinical safety findings with first generation molecule",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:07.280063+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 22,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "e07505b4-fdf0-416e-9ef3-2a49cb232aab",
        "evidence": "chart/bar-vertical: Fraction Unbound Concentrations (C24h) [AB-161]free: plasma",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:20:07.363872+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 23,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "0b4fdba6-cf9b-4266-9e83-00de851f4657",
        "evidence": "chart/bar-vertical: Fraction Unbound Concentrations (C24h) [AB-161]free: liver",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:20:07.405369+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 23,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "7a0b1633-5b78-423b-8a92-d21745c29754",
        "evidence": "list/bullet: Cause & Symptoms: Coronavirus Infections, such as COVID-19 caused by SARS-CoV-2; Spreads through breathing out droplets; Older adults at higher risk; Virus continues to mutate.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:07.48856+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 24,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "fb62b143-f1ec-4544-9467-0e86fe7735a0",
        "evidence": "list/bullet: Safety: Highly selective for coronavirus Mpro vs human proteases, Clean cell toxicity profile, Off-target assessment results unremarkable",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:20:07.612178+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 26,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Table data",
          "slug": "table-data",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
          "version": 1,
          "bodyDocId": null,
          "description": "Tabular layouts of structured data.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "cdc8915b-bd88-402e-a33c-6c5832dec8b3",
        "evidence": "table/data: Milestone and Anticipated Timing 2023 table",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:20:07.692674+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 27,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Storytelling: the closing ask",
          "slug": "closing-ask",
          "status": "active",
          "bestFor": null,
          "canonId": "019df269-24e0-70ab-8dd9-983832c1c665",
          "version": 1,
          "bodyDocId": "019df269-24bc-7554-b88d-245127606b8d",
          "description": "The single most important slide in the deck — after the cover. The final",
          "familyLabel": "narrative-block",
          "categoryName": "Narrative & Transformation",
          "categorySlug": "narrative-transformation"
        },
        "agent": "storyteller",
        "layer": "slide",
        "agents": [
          "storyteller"
        ],
        "matchId": "9ad80852-4f11-4718-a47b-ff4af1eda049",
        "evidence": "title/headline: Thank You",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:20:07.773096+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 28,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      }
    ],
    "frameworks": [
      {
        "matchId": "5a2475b7-4243-4fb4-9959-d44536890c8c",
        "evidence": "Visual representation of project timelines across phases",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 12:05:49.219+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 5,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "50e8903c-e28d-4332-8768-bea5945ca7e0",
        "evidence": "Nested circles representing the funnel from total population to treated patients",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 12:05:54.589+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 7,
        "frameworkName": "market-segmentation-pyramid"
      },
      {
        "matchId": "9be4eacb-9d8e-4894-99a3-f7cea8068df1",
        "evidence": "The diagram maps specific therapeutic actions to a final outcome (HBV Cure).",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 12:05:50.416+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 8,
        "frameworkName": "causal-chain"
      },
      {
        "matchId": "a12d5117-4adf-4ef6-b9d4-148a23c3d58e",
        "evidence": "The slide uses a horizontal axis with weeks to show the progression of a clinical trial.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 12:05:54.749+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 17,
        "frameworkName": "timeline"
      },
      {
        "matchId": "1e080998-4edc-4036-9385-133d7a2a689b",
        "evidence": "Visual representation of clinical trial phases over time.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 12:05:52.338+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 18,
        "frameworkName": "timeline"
      }
    ],
    "patterns": []
  },
  "storymakers": null,
  "score": null,
  "review": null,
  "activistThesis": null,
  "pitchdeck": {
    "metadata": null,
    "profile": null
  },
  "slides": [
    {
      "page": 1,
      "type": "setup",
      "function": "front_matter",
      "imagePath": "https://imgproxy.kitesheet.com/lf-Jx0aAFQ3VvknbyExwb4cendDE8laAH1DjOtX0DnM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMmE4ODBhZDBjNTI2NTI3ZmU4YWE0OWM0MDI3MDIyNC9wMDAxLmpwZw",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 31,
        "componentCount": 5,
        "textChars": 114,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:49.119+00",
          "seconds": 2.24,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/1",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-1",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.18,
            "x": 0.8,
            "y": 0.95
          },
          "kind": "disclaimer",
          "text": "© 2023 Arbutus Biopharma, Inc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.119+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f6522044-1e6c-45bb-ba00-645bedb1e33f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.23,
            "x": 0.07,
            "y": 0.15
          },
          "kind": "image",
          "text": "Arbutus Biopharma",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.119+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d88ce464-ad82-462c-9876-d5139cdf88b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.7,
            "w": 0.4,
            "x": 0.55,
            "y": 0.1
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.119+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e21d024d-79e9-401c-975d-5f61fa9c8ced",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.07,
            "y": 0.58
          },
          "kind": "paragraph",
          "text": "NASDAQ: ABUS\nwww.arbutusbio.com\nMarch 2, 2023",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.119+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "75fc3b72-c6ec-4a0c-9e5c-e497d4174ba8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.3,
            "x": 0.07,
            "y": 0.375
          },
          "kind": "title",
          "text": "Corporate Presentation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.119+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f858c37c-aefe-4d15-b16c-6aef38b76743",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Slide recipe: Cover",
            "slug": "cover-slide",
            "status": "active",
            "bestFor": null,
            "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3",
            "version": 1,
            "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65",
            "description": "The first ten seconds. Build it deliberately.",
            "familyLabel": "slide-recipe",
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "designer",
          "layer": "slide",
          "agents": [
            "designer"
          ],
          "matchId": "2ff07bb0-e0a5-44b7-a469-ca198aa6851e",
          "evidence": "title/headline: Corporate Presentation",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:20:05.618074+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 1,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "thumbSrc": "https://imgproxy.kitesheet.com/OWcN49p8o7RE5-QVLjH33h9NJ-Td8RZjh0qpUi__tW8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMmE4ODBhZDBjNTI2NTI3ZmU4YWE0OWM0MDI3MDIyNC9wMDAxLmpwZw",
      "imagePathAlt": "https://imgproxy.kitesheet.com/tb-lp8F0I5fBBmixX6IsLi3K3QuM2ldOcSHbZTrkgic/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMmE4ODBhZDBjNTI2NTI3ZmU4YWE0OWM0MDI3MDIyNC9wMDAxLnBuZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/d326NUbCDiEgqhpKe1tEKmNuXElqY2nS36TuHCozzoc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMmE4ODBhZDBjNTI2NTI3ZmU4YWE0OWM0MDI3MDIyNC9wMDAxLnBuZw"
    },
    {
      "page": 2,
      "type": "setup",
      "function": "other",
      "rawType": "disclaimer",
      "block": null,
      "metadata": {
        "slideType": "disclaimer",
        "slideTypeCanon": {
          "name": "Disclaimer",
          "slug": "disclaimer",
          "status": "active",
          "canonId": "019de52d-0801-727b-b98a-5ed095aeee78",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 20,
        "componentCount": 2,
        "textChars": 289,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:51.789+00",
          "seconds": 4.638,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/2",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-2",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.685,
            "w": 0.848,
            "x": 0.076,
            "y": 0.181
          },
          "kind": "disclaimer",
          "text": "This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. All statements that are not historical facts are hereby identified as forward-looking statements...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.789+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "36a5943f-83b9-4ef5-a726-4469057b80aa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.055,
            "w": 0.498,
            "x": 0.076,
            "y": 0.065
          },
          "kind": "title",
          "text": "Forward-Looking Statements",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.789+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c2712964-a782-402f-935c-66f67f2c0440",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 3,
      "type": "setup",
      "function": "present_solution",
      "rawType": "key_messages",
      "block": null,
      "metadata": {
        "slideType": "key_messages",
        "slideTypeCanon": {
          "name": "Key messages",
          "slug": "key_messages",
          "status": "active",
          "canonId": "019de52d-0712-703f-89f5-bda6688faf3f",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 7,
        "textChars": 671,
        "nDataPoints": 1,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:50.023+00",
          "seconds": 2.843,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/3",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-3",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.13,
            "w": 0.18,
            "x": 0.11,
            "y": 0.388
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Icon grid",
              "slug": "icon-grid",
              "status": "active",
              "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "icon-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1ec32427-4f1a-4bb9-b3cd-f218db563fe4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.18,
            "x": 0.56,
            "y": 0.388
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Icon grid",
              "slug": "icon-grid",
              "status": "active",
              "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "icon-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "db79f056-9f4d-419c-a772-2e0392c76173",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.35,
            "x": 0.56,
            "y": 0.575
          },
          "kind": "paragraph",
          "text": "Develop novel oral pan coronavirus antivirals targeting essential viral proteins with the goal of reducing hospitalizations and providing pre-exposure prophylactic therapy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2cdc4396-58f8-4dff-891e-aa7f4e3cb354",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.848,
            "x": 0.076,
            "y": 0.16
          },
          "kind": "paragraph",
          "text": "Leverage the proven track record of success established with our team's expertise in understanding and treating viral infections by discovering and developing a broad, differentiated pipeline of therapies targeting chronic HBV, COVID-19, and future coronavirus outbreaks.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d8675ce0-6e36-40b4-b259-21cbac2fba5e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.35,
            "x": 0.11,
            "y": 0.575
          },
          "kind": "paragraph",
          "text": "Develop a combination therapy that includes antivirals and immunologics to provide a finite duration treatment for people with cHBV that results in >20% functional cure rate.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f5d2fefe-c42c-4bd1-9be0-cb73fe064faa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.169,
            "y": 0.945
          },
          "kind": "source-note",
          "text": "HBV: Hepatitis B Virus | cHBV: chronic HBV",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "77aa094e-8212-4dc8-8339-e073a6c9046b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.26,
            "x": 0.076,
            "y": 0.065
          },
          "kind": "title",
          "text": "Our Strategy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9381554a-48a4-4b9e-b763-bfaaeb26b09c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 4,
      "type": "setup",
      "title": "Includes a legend for technical acronyms at the bottom.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 5,
        "textChars": 512,
        "nDataPoints": 1,
        "notes": "Includes a legend for technical acronyms at the bottom.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:49.877+00",
          "seconds": 2.678,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/4",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-4",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.9,
            "x": 0.05,
            "y": 0.18
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Icon grid",
              "slug": "icon-grid",
              "status": "active",
              "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "icon-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.877+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7eb984a8-e256-4bd7-b72e-ebde8020cc24",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.14,
            "y": 0.92
          },
          "kind": "legend",
          "text": "MOA: Mechanism of Action | PD-L1: Programmed death-ligand 1 | Mpro: Main protease | NSP12: Non-structural protein | HBsAg: Hepatitis B surface antigen",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.877+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "957c1a88-b27d-4627-aae7-82f47ea2360b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.6
          },
          "kind": "list",
          "text": "Focused on HBV/coronavirus; Discovered/developed multiple drugs; RNAi/PD-L1/Mpro/Nsp12 assets; AB-729 safety/efficacy data; Cash runway into Q4 2024; Licensing royalties",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.877+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e725e4b-14b8-4411-b31c-9b9b57fa8cc6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "list",
          "text": "Indications with significant unmet medical need; Team with virology expertise; Broad portfolio; Lead HBV compound AB-729; Strong financial position; Patented LNP technology",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.877+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7edf1e17-5e6e-4b54-a648-52ec169ab0e0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.3,
            "x": 0.07,
            "y": 0.05
          },
          "kind": "title",
          "text": "Investment Highlights",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.877+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0205b926-9da6-4fa1-9f68-7a07a0ff6e5e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Executive summary",
            "slug": "executive-summary",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
            "version": 1,
            "bodyDocId": null,
            "description": "A condensed view of the entire argument on a single slide / block.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "d033ce20-6bdc-4f07-a572-a229cb029268",
          "evidence": "list/bullet: Indications with significant unmet medical need; Team with virology expertise; Broad portfolio; Lead HBV compound AB-729; Strong financial position; Patented LNP technology",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:20:05.781946+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 4,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 5,
      "type": "resolution",
      "title": "The chart uses a Gantt-style visualization to represent drug development stages.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 11,
        "componentCount": 3,
        "textChars": 58,
        "nDataPoints": 0,
        "notes": "The chart uses a Gantt-style visualization to represent drug development stages.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:49.219+00",
          "seconds": 2.006,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/5",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-5",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.928,
            "x": 0.036,
            "y": 0.177
          },
          "kind": "chart",
          "text": "Pipeline status chart",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "gantt-chart",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.219+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3542d724-ce71-4286-be95-92d0e5a7046d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.16,
            "x": 0.162,
            "y": 0.945
          },
          "kind": "source-note",
          "text": "NA: Nucleoside Analogue",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.219+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0b88b369-066e-4d43-828c-57c2057bc7dd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.29,
            "x": 0.076,
            "y": 0.06
          },
          "kind": "title",
          "text": "Broad Pipeline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:49.219+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c1df8de7-8f14-4ed1-89fb-576e064edb5e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Gantt chart",
            "slug": "gantt-chart",
            "status": "active",
            "bestFor": null,
            "canonId": "019de52d-1fa2-7206-bb14-bb9ff5fccdba",
            "version": 1,
            "bodyDocId": null,
            "description": null,
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "04de32d1-7e2c-435a-9288-664b702ab7d4",
          "evidence": "chart/gantt-chart: Pipeline status chart",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:20:06.368916+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 5,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "5a2475b7-4243-4fb4-9959-d44536890c8c",
          "evidence": "Visual representation of project timelines across phases",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 12:05:49.219+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 5,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 6,
      "type": "setup",
      "title": "The slide uses a four-column layout to structure the disease overview.",
      "function": "establish_context",
      "rawType": "context",
      "block": null,
      "metadata": {
        "slideType": "context",
        "slideTypeCanon": {
          "name": "Context (pitchdeck)",
          "slug": "context",
          "status": "active",
          "canonId": "019de52d-1094-779e-9590-e4603e6a191c",
          "version": 1,
          "description": null
        },
        "function": "establish_context",
        "functionCanon": {
          "name": "Establish context",
          "slug": "establish_context",
          "status": "active",
          "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 70,
        "componentCount": 7,
        "textChars": 476,
        "nDataPoints": 1,
        "notes": "The slide uses a four-column layout to structure the disease overview.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:51.48+00",
          "seconds": 3.788,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/6",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-6",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.42,
            "x": 0.16,
            "y": 0.94
          },
          "kind": "legend",
          "text": "HBsAg: HBV Surface Antigen | HCC: Hepatocellular carcinoma",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d4799681-2d40-4da8-959d-017fa50611ee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.21,
            "x": 0.76,
            "y": 0.23
          },
          "kind": "list",
          "text": "Rationale: Need for finite, efficacious treatments; combination therapy requirement.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "63fff732-cb7c-4512-9cec-5c52f8e3080f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.21,
            "x": 0.04,
            "y": 0.23
          },
          "kind": "list",
          "text": "Cause & Symptoms: Life-threatening liver infection, transmission, chronic infection risks.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8c991839-053b-4c87-89bd-ccc52e427fff",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.21,
            "x": 0.28,
            "y": 0.23
          },
          "kind": "list",
          "text": "Diagnosis: HBsAg detection, additional biomarkers.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d065797c-7d77-40a6-b254-4d7decfa4bf0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.21,
            "x": 0.52,
            "y": 0.23
          },
          "kind": "list",
          "text": "Treatments: NA therapy, Peg-IFNa, <5% functional cure rate.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d244638b-79f8-47d5-8ad5-21a9022b0b87",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.76,
            "x": 0.056,
            "y": 0.83
          },
          "kind": "source-note",
          "text": "Sources for all data on slide: 1 Hepatitis B Fact Sheet, WHO... 2 Pegasys, PEG-Intron, Baraclude and Viread Package Inserts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5b5f4c1-cf7c-4bc2-8dd7-8c995b9b9844",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.055,
            "w": 0.287,
            "x": 0.076,
            "y": 0.06
          },
          "kind": "title",
          "text": "HBV Overview",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.48+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1979a883-c184-42a8-98db-ab198e560ac5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "fc9395ba-5e9a-4b0a-b66f-ac004b6642d9",
          "evidence": "list/bullet: Cause & Symptoms: Life-threatening liver infection, transmission, chronic infection risks.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:06.439058+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 6,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 7,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 6,
          "name": "Problem",
          "beatId": "9efdc5e5-038d-4e00-a590-e4a91a4f4a25",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Problem (Identify pain)",
            "slug": "problem-agitate-solution-problem-identify-pain",
            "status": "active",
            "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131",
            "version": 1,
            "description": null
          },
          "evidence": "The document identifies HBV as a significant unmet medical need (p6-7).",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 7,
      "type": "tension",
      "title": "Uses a geographic map and a nested circle diagram to illustrate the treatment gap.",
      "function": "frame_problem",
      "rawType": "problem_statement",
      "block": null,
      "metadata": {
        "slideType": "problem_statement",
        "slideTypeCanon": {
          "name": "Problem statement",
          "slug": "problem_statement",
          "status": "active",
          "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4",
          "version": 1,
          "description": null
        },
        "function": "frame_problem",
        "functionCanon": {
          "name": "Frame problem",
          "slug": "frame_problem",
          "status": "active",
          "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 73,
        "componentCount": 7,
        "textChars": 478,
        "nDataPoints": 8,
        "notes": "Uses a geographic map and a nested circle diagram to illustrate the treatment gap.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:54.589+00",
          "seconds": 6.831,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/7",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-7",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.25,
            "x": 0.75,
            "y": 0.17
          },
          "kind": "diagram",
          "text": "Nested circles showing >290M total, 30M diagnosed, 6.6M treated",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "other",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f0e7ec11-3490-4f21-9f2a-ae6932cab658",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.55,
            "x": 0.07,
            "y": 0.25
          },
          "kind": "image",
          "text": "Global map showing HBV prevalence by region",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Map",
              "slug": "map",
              "status": "active",
              "canonId": "019de52c-fe4d-77bd-b0a4-d72d58b9e5a4",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "map",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a192311a-a53f-413d-bf63-bfc1bf96aada",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.1,
            "x": 0.16,
            "y": 0.95
          },
          "kind": "legend",
          "text": "SOC: Standard of Care",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1258f069-7e2b-4f04-b2d7-dbb6b43842ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.15,
            "x": 0.07,
            "y": 0.17
          },
          "kind": "paragraph",
          "text": ">290M people are chronically infected with HBV, globally.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "18538f42-ede2-47cb-bd6b-affcac38975b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.15,
            "x": 0.07,
            "y": 0.7
          },
          "kind": "paragraph",
          "text": "~820k people die every year as a consequence despite the availability of effective vaccines and antivirals.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1aacc877-fa56-4d36-9657-3b6ccb04856a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.37,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Sources: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b https://www.hepb.org/what-is-hepatitis-b/what-is-hepb/facts-and-figures/",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1eb61fcd-9a16-483b-847c-fa66c15b18aa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.7,
            "x": 0.07,
            "y": 0.06
          },
          "kind": "title",
          "text": "HBV Presents a Significant Unmet Medical Need",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "de81f945-2f27-4786-992f-791f8b072053",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Problem Statement Canvas",
            "slug": "problem-statement-canvas",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18",
            "version": 1,
            "bodyDocId": null,
            "description": "Structured definition of the problem: What? Who? Where? When? Scale?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Architect",
          "layer": "slide",
          "agents": [
            "Architect"
          ],
          "matchId": "897a0716-6e77-49e3-9d30-eab8d1c1555a",
          "evidence": "type: problem_statement",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:20:06.509922+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 7,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "50e8903c-e28d-4332-8768-bea5945ca7e0",
          "evidence": "Nested circles representing the funnel from total population to treated patients",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 12:05:54.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 7,
          "frameworkName": "market-segmentation-pyramid"
        }
      ],
      "arcBeats": [
        {
          "to": 7,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 6,
          "name": "Problem",
          "beatId": "9efdc5e5-038d-4e00-a590-e4a91a4f4a25",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Problem (Identify pain)",
            "slug": "problem-agitate-solution-problem-identify-pain",
            "status": "active",
            "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131",
            "version": 1,
            "description": null
          },
          "evidence": "The document identifies HBV as a significant unmet medical need (p6-7).",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 7,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 7,
          "name": "Complication",
          "beatId": "bc9bddc7-5053-4090-b64a-3a6d7a5459d0",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Agitate (Make it worse)",
            "slug": "problem-agitate-solution-agitate-make-it-worse",
            "status": "active",
            "canonId": "019dd9b8-0f5a-71dd-bae7-8fadb0d09456",
            "version": 1,
            "description": null
          },
          "evidence": "The document highlights the limitations of current treatments (p7).",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 8,
          "from": 7,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "b3e8d7b9-0084-4114-a08f-62c827296b2f",
          "evidence": "The document highlights the unmet medical need and the limitations of current treatments (p7-8).",
          "position": 0,
          "objective": "What is the cost of not addressing HBV?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:25:42.213917+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 8,
      "type": "resolution",
      "title": "The slide uses a process-oriented diagram to show how three distinct mechanisms of action (MOAs) combine to lead to a clinical outcome.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 29,
        "componentCount": 4,
        "textChars": 225,
        "nDataPoints": 0,
        "notes": "The slide uses a process-oriented diagram to show how three distinct mechanisms of action (MOAs) combine to lead to a clinical outcome.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:50.416+00",
          "seconds": 2.611,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/8",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-8",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.65,
            "x": 0.3,
            "y": 0.09
          },
          "kind": "diagram",
          "text": "Suppress, Reduce, Boost process flow",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.416+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f297bce2-0617-4dda-ad84-f88a03d4892b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.22,
            "x": 0.038,
            "y": 0.48
          },
          "kind": "list",
          "text": "Suppress HBV DNA; Reduce viral antigens; Boost host immune response",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.416+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6f5b940c-3b3f-4d76-acdb-ee6aa5284985",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.22,
            "x": 0.038,
            "y": 0.76
          },
          "kind": "paragraph",
          "text": "Therapeutic success will require a combination of agents with complementary MOAs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.416+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "88657fe5-996a-411a-8a66-62d63d614600",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.22,
            "x": 0.038,
            "y": 0.09
          },
          "kind": "title",
          "text": "3-Pronged Approach to Therapeutic Success",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.416+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7b2ac3c1-b9b1-4723-aa83-00448a55bea1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "0e52eddb-9285-4afe-92f0-bc6c95b0e185",
          "evidence": "list/bullet: Suppress HBV DNA; Reduce viral antigens; Boost host immune response",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:06.579903+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 8,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Process flow",
            "slug": "process-flow",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4dca-76bc-8135-401836a1c4c0",
            "version": 1,
            "bodyDocId": null,
            "description": "Workflow, steps, sequential diagram.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "0367a621-df45-4dc4-805d-c84935c17b75",
          "evidence": "diagram/process: Suppress, Reduce, Boost process flow",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:20:06.614305+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 8,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "9be4eacb-9d8e-4894-99a3-f7cea8068df1",
          "evidence": "The diagram maps specific therapeutic actions to a final outcome (HBV Cure).",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 12:05:50.416+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 8,
          "frameworkName": "causal-chain"
        }
      ],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 8,
          "from": 7,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "b3e8d7b9-0084-4114-a08f-62c827296b2f",
          "evidence": "The document highlights the unmet medical need and the limitations of current treatments (p7-8).",
          "position": 0,
          "objective": "What is the cost of not addressing HBV?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:25:42.213917+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 9,
      "type": "resolution",
      "title": "Includes a schematic of the GalNAc-linker-RNAi construct and a bar chart illustrating the suppression of various HBV transcripts.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 48,
        "componentCount": 5,
        "textChars": 421,
        "nDataPoints": 0,
        "notes": "Includes a schematic of the GalNAc-linker-RNAi construct and a bar chart illustrating the suppression of various HBV transcripts.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:54.216+00",
          "seconds": 6.387,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/9",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-9",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.25,
            "w": 0.5,
            "x": 0.44,
            "y": 0.65
          },
          "kind": "chart",
          "text": "HBV transcript suppression chart",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.216+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "47265d89-6877-454f-abb6-b06fcde23c12",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.32,
            "x": 0.08,
            "y": 0.68
          },
          "kind": "image",
          "text": "GalNAc-Linker-RNAi schematic",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.216+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "862ef6ba-d82c-4585-bd79-98d78228294c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.5,
            "x": 0.44,
            "y": 0.18
          },
          "kind": "list",
          "text": "Single trigger RNAi agent targeting all HBV transcripts; Inhibits HBV replication and lowers all HBV antigens; Pan-genotypic activity; Demonstrated complementarity; Actively targets liver; Active against cccDNA; Clean safety profile.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.216+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "86dae521-4d42-45b2-9977-369ae04767d2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.28,
            "x": 0.08,
            "y": 0.46
          },
          "kind": "paragraph",
          "text": "Proprietary GalNAc-conjugate delivery technology provides liver targeting and enables subcutaneous dosing",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.216+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3c58a766-f37a-4e6a-84ac-a5433b7ecb6c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.08,
            "y": 0.24
          },
          "kind": "title",
          "text": "AB-729 RNAi Therapeutic",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.216+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "985b68b7-50a9-459a-a7c4-aabbfbb32f94",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "26cf00af-3af8-4e18-b6cc-a60ec584b746",
          "evidence": "list/bullet: Single trigger RNAi agent targeting all HBV transcripts; Inhibits HBV replication and lowers all HBV antigens; Pan-genotypic activity; Demonstrated complementarity; Actively targets liver; Active against ccc",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:06.683309+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 9,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 10,
      "type": "setup",
      "title": "The slide outlines the study structure for a clinical trial, categorizing cohorts by dosage and patient status (HBV DNA +/-).",
      "function": "present_framework",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "present_framework",
        "functionCanon": {
          "name": "Present framework",
          "slug": "present_framework",
          "status": "active",
          "canonId": "019de52d-1403-7667-9100-d2ac6709f750",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 41,
        "componentCount": 5,
        "textChars": 281,
        "nDataPoints": 0,
        "notes": "The slide outlines the study structure for a clinical trial, categorizing cohorts by dosage and patient status (HBV DNA +/-).",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:53.727+00",
          "seconds": 5.8,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/10",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-10",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.42,
            "x": 0.33,
            "y": 0.17
          },
          "kind": "diagram",
          "text": "Part 3: Multiple Ascending Dose in cHBV Patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.727+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a2a576d2-8997-41b7-ac7f-8c0bc7dc69ae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.33,
            "y": 0.93
          },
          "kind": "disclaimer",
          "text": "HBeAg: HBV E antigen | TDF: tenofovir disoproxil fumarate\nData presented at EASL 2022",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.727+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fc984dc4-ec99-42fd-94b2-20194a8afc5b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.04,
            "y": 0.54
          },
          "kind": "list",
          "text": "Robust HBsAg declines across all cohorts\nHBV DNA declines in HBV DNA+ patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.727+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d403aa46-7a46-47da-acb0-28351e56b3e1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.18,
            "x": 0.04,
            "y": 0.22
          },
          "kind": "paragraph",
          "text": "Part 1 & 2: Single-ascending dose",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.727+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "11a73fc2-333c-4840-83fc-91662a4b2024",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.55,
            "x": 0.07,
            "y": 0.06
          },
          "kind": "title",
          "text": "AB-729-001 Phase 1a/1b Clinical Trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.727+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "751722c8-bd08-4c75-bead-5ff0b8324984",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "c280fa0a-28a7-4628-a36d-e5e57d7d2b94",
          "evidence": "list/bullet: Robust HBsAg declines across all cohorts",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:06.753405+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 10,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 14,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 10,
          "name": "Evidence & Proof",
          "beatId": "5dda647e-e3c1-4360-9757-fc347cc61491",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Evidence & Proof",
            "slug": "consultants-gambit-evidence-proof",
            "status": "active",
            "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents data and results from clinical trials, including AB-729-001 (p10-14).",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 11,
      "type": "analysis",
      "title": "Data presented at EASL 2022 and AASLD 2022.",
      "function": "analyze_data",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 4,
        "textChars": 624,
        "nDataPoints": 36,
        "notes": "Data presented at EASL 2022 and AASLD 2022.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:51.594+00",
          "seconds": 3.624,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/11",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-11",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.45,
            "w": 0.33,
            "x": 0.65,
            "y": 0.28
          },
          "kind": "list",
          "text": "Mean declines in HBsAg on treatment and post treatment continue to be comparable across cohorts. Results to date from a dedicated HBeAg+ cohort (Cohort K) further support preliminary observations suggesting that baseline HBeAg status has no negative effect on response. Sustained HBsAg suppression up to 24 weeks post last dose",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b3c37e91-5d6f-491e-9c58-52374a409c85",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.55,
            "x": 0.08,
            "y": 0.77
          },
          "kind": "source-note",
          "text": "Data shown as mean (SE) log10 IU/mL; Last AB-729 dose Cohort E: Week 44, Cohorts F, I, G, K: Week 40, Cohort J: Week 36; HBsAg Assay LLOQ = 0.07 IU/mL; *N=6; #N=5",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e452720a-c50d-4cf9-a2ca-9baf213be906",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.48,
            "w": 0.63,
            "x": 0.08,
            "y": 0.245
          },
          "kind": "table",
          "text": "Mean (SE) Baseline and Δ log10 HBsAg by Visit table",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee0801eb-dfea-4760-a3a7-6e29d3643868",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.05
          },
          "kind": "title",
          "text": "Robust HBsAg Declines Irrespective of Dose, Dosing Schedule, HBeAg or HBV DNA Status",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "05503c07-6346-4c34-8c9c-0d169b314aea",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Table data",
            "slug": "table-data",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
            "version": 1,
            "bodyDocId": null,
            "description": "Tabular layouts of structured data.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "5eb7fcf4-2d60-46eb-a50c-4fd26acca928",
          "evidence": "table/data: Mean (SE) Baseline and Δ log10 HBsAg by Visit table",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:20:06.823713+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 11,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 14,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 10,
          "name": "Evidence & Proof",
          "beatId": "5dda647e-e3c1-4360-9757-fc347cc61491",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Evidence & Proof",
            "slug": "consultants-gambit-evidence-proof",
            "status": "active",
            "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents data and results from clinical trials, including AB-729-001 (p10-14).",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 12,
      "type": "evidence",
      "title": "The slide displays longitudinal data for cohorts E, F, I, J, G, and K, highlighting individual patient responses and key clinical outcomes.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 32,
        "componentCount": 3,
        "textChars": 277,
        "nDataPoints": 6,
        "notes": "The slide displays longitudinal data for cohorts E, F, I, J, G, and K, highlighting individual patient responses and key clinical outcomes.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:50.696+00",
          "seconds": 2.632,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/12",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-12",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.65,
            "x": 0.07,
            "y": 0.25
          },
          "kind": "chart",
          "text": "Change in HBsAg vs time across 6 cohorts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.696+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b92c986f-cfb4-4fa8-b553-632a9229b0a8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.3,
            "x": 0.68,
            "y": 0.25
          },
          "kind": "list",
          "text": "33 of 41 patients had HBsAg < 100 IU/mL at some point during the trial. 1 patient in Cohort E seroconverted. 2 patients in Cohort K reached HBsAg < LLOQ.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.696+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee4e3a6f-02ef-4979-a04f-b0969d29e967",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.07,
            "y": 0.05
          },
          "kind": "title",
          "text": "AB-729-001: Robust & Sustained HBsAg Declines While On- or Off-Treatment with AB-729",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.696+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e028b15f-a800-40c7-8959-b97bdabea116",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 14,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 10,
          "name": "Evidence & Proof",
          "beatId": "5dda647e-e3c1-4360-9757-fc347cc61491",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Evidence & Proof",
            "slug": "consultants-gambit-evidence-proof",
            "status": "active",
            "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents data and results from clinical trials, including AB-729-001 (p10-14).",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 13,
      "type": "evidence",
      "title": "The slide displays 8 individual patient case studies (Pt 46, 51, 52, 53, 56, 58, 59, 60, 61).",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 58,
        "componentCount": 5,
        "textChars": 460,
        "nDataPoints": 8,
        "notes": "The slide displays 8 individual patient case studies (Pt 46, 51, 52, 53, 56, 58, 59, 60, 61).",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:51.594+00",
          "seconds": 3.499,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/13",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-13",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.7,
            "x": 0.15,
            "y": 0.85
          },
          "kind": "callout",
          "text": "HBV DNA has transiently increased in some patients and subsequently decreased with no intervention",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9fd5448c-a463-426e-be99-fb0cecb1b08e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.94,
            "x": 0.03,
            "y": 0.23
          },
          "kind": "chart",
          "text": "Individual patient longitudinal biomarker charts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2692bd3b-9ea9-47f4-89a5-d79d05eecbdb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.55,
            "x": 0.29,
            "y": 0.925
          },
          "kind": "disclaimer",
          "text": "* Patient 53 restarted NA therapy at Investigator’s request after the NA d/c FU W20 visit (pink shaded area). ** Patient 58 restarted therapy after the NA d/c FU W36 visit.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1f86c69d-c4cb-4adc-a5f3-e185c388138e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.23,
            "x": 0.385,
            "y": 0.785
          },
          "kind": "legend",
          "text": "HBsAg (red), ALT (green), HBV DNA (blue)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eb692cf1-cc35-4439-bf82-793e61ac8e4a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.86,
            "x": 0.07,
            "y": 0.05
          },
          "kind": "title",
          "text": "AB-729-001: AB-729 Shows Meaningful Suppression of HBV Biomarkers in cHBV Patients While Off-Treatment",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fdb60ceb-22e1-4b72-ac4e-205059c45056",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 14,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 10,
          "name": "Evidence & Proof",
          "beatId": "5dda647e-e3c1-4360-9757-fc347cc61491",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Evidence & Proof",
            "slug": "consultants-gambit-evidence-proof",
            "status": "active",
            "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents data and results from clinical trials, including AB-729-001 (p10-14).",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 14,
      "type": "evidence",
      "title": "Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.",
      "function": "analyze_data",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 60,
        "componentCount": 5,
        "textChars": 485,
        "nDataPoints": 12,
        "notes": "Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:50.719+00",
          "seconds": 2.502,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/14",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-14",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.3,
            "w": 0.7,
            "x": 0.04,
            "y": 0.6
          },
          "kind": "chart",
          "text": "AB-729 Decreased Exhausted T-Cells",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Grouped bar chart",
              "slug": "bar-grouped",
              "status": "active",
              "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-grouped",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.719+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0d0860d1-145a-4026-9fd7-5e3906de34a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.7,
            "x": 0.04,
            "y": 0.22
          },
          "kind": "chart",
          "text": "AB-729 Increased HBV-Specific T-Cell Activation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.719+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2b1a1ac8-f41c-4536-b638-1a96b10a1e2f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.25,
            "x": 0.72,
            "y": 0.5
          },
          "kind": "list",
          "text": "Upregulation of HBV-specific T-cell activation markers observed in all 7 patients assessed to date. Two profiles of HBV-specific T cell IFN-y responses observed. Elevation between Wk 16-28 which coincides with nadir of HBsAg reduction. Elevation after AB-729 dosing completed, between Wk 48-60",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.719+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "96e7499a-2da0-41e3-9262-4eb4a238302c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.15,
            "x": 0.56,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Data presented at EASL 2022",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.719+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1182ae2d-b42e-46fd-9401-f85a6b6949ce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.04,
            "y": 0.04
          },
          "kind": "title",
          "text": "AB-729-001: Treatment with AB-729 Reactivates HBV Specific Immunity in Some Patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.719+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "886ea60d-d31d-4c53-a9ad-1bc454c14c5f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 14,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 10,
          "name": "Evidence & Proof",
          "beatId": "5dda647e-e3c1-4360-9757-fc347cc61491",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Evidence & Proof",
            "slug": "consultants-gambit-evidence-proof",
            "status": "active",
            "canonId": "019dd9b8-07b1-7688-8e1e-7637fec3802a",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents data and results from clinical trials, including AB-729-001 (p10-14).",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 15,
      "type": "setup",
      "title": "The slide uses a bulleted list with custom circular icons to present clinical safety findings.",
      "function": "summarize",
      "rawType": "appendix_disclosure",
      "block": null,
      "metadata": {
        "slideType": "appendix_disclosure",
        "slideTypeCanon": {
          "name": "Appendix disclosure",
          "slug": "appendix_disclosure",
          "status": "active",
          "canonId": "019de52d-07b2-7549-8e8b-932a19f6e616",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 36,
        "componentCount": 3,
        "textChars": 520,
        "nDataPoints": 0,
        "notes": "The slide uses a bulleted list with custom circular icons to present clinical safety findings.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:50.655+00",
          "seconds": 2.435,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/15",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-15",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.025,
            "w": 0.243,
            "x": 0.144,
            "y": 0.948
          },
          "kind": "disclaimer",
          "text": "SAE: Serious Adverse Event | AE: Adverse Event",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.655+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e9b816c2-0a70-4339-ab89-a70329585eee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.495,
            "w": 0.805,
            "x": 0.076,
            "y": 0.235
          },
          "kind": "list",
          "text": "AB-729 is generally safe and well-tolerated after repeat dosing for up to 48 weeks; No treatment-related SAEs or discontinuations due to AEs; No treatment-related Grade 3 or 4 AEs; No treatment-related Grade 3 or 4 laboratory abnormalities; Grade 1 and Grade 2 ALT elevations have improved or stabilized with continued treatment; Injection site AEs were all Grade 1 (erythema, pain, bruising); No clinically meaningful changes in ECGs or vital signs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.655+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7bdaf777-57b9-48c8-800c-0527f9624193",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.085,
            "w": 0.498,
            "x": 0.076,
            "y": 0.065
          },
          "kind": "title",
          "text": "AB-729-001 Safety Summary",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:50.655+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a9c16d7d-abb3-47b4-a3ac-e8ef0a256452",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "2d76ca3b-ed5f-46a6-93ea-5486e2d94cc2",
          "evidence": "list/bullet: AB-729 is generally safe and well-tolerated after repeat dosing for up to 48 weeks; No treatment-related SAEs or discontinuations due to AEs; No treatment-related Grade 3 or 4 AEs; No treatment-related Grade",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:07.006891+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 15,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 16,
      "type": "resolution",
      "title": "Data presented at AASLD 2022.",
      "function": "summarize",
      "rawType": "key_takeaways",
      "block": null,
      "metadata": {
        "slideType": "key_takeaways",
        "slideTypeCanon": {
          "name": "Key takeaways",
          "slug": "key_takeaways",
          "status": "active",
          "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 72,
        "componentCount": 6,
        "textChars": 709,
        "nDataPoints": 4,
        "notes": "Data presented at AASLD 2022.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:51.469+00",
          "seconds": 3.117,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/16",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-16",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.5,
            "w": 0.23,
            "x": 0.27,
            "y": 0.27
          },
          "kind": "list",
          "text": "Discontinuation of both AB-729 and NA-therapy results in a sustained reduction in HBsAg. No evidence of virologic or biochemical relapse detected in 9 patients who discontinued all therapy from 12 to 44 weeks.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.469+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14b6f068-4201-457f-b16f-fd7d76baf6e1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.21,
            "x": 0.76,
            "y": 0.27
          },
          "kind": "list",
          "text": "AB-729 was generally safe and well-tolerated after completing dosing in 41 patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.469+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3352c0ad-ded8-4749-ae5e-52545c27ebef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.23,
            "x": 0.025,
            "y": 0.27
          },
          "kind": "list",
          "text": "AB-729 provided robust and comparable HBsAg declines regardless of dose, dosing interval, HBeAg or DNA status. ~75% (26 of 34) patients had HBsAg levels <100 at some point. 50% (16 of 32) maintained HBsAg <100 IU/mL for 24 weeks after stopping.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.469+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cfb7908b-bd11-4248-aba4-394aa458c7d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.23,
            "x": 0.515,
            "y": 0.27
          },
          "kind": "list",
          "text": "AB-729 continues to result in HBV-specific T-cell immune restoration and decrease of exhausted T-cells.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.469+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef650110-cfb2-48c4-ab77-e77d3609432d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.15,
            "x": 0.15,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "* Data presented at AASLD 2022",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.469+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aee34846-1a79-495e-92a1-ad1fde1df984",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.55,
            "x": 0.075,
            "y": 0.06
          },
          "kind": "title",
          "text": "AB-729-001 Clinical Trial Key Takeaways",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:51.469+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f2a3769a-aaa8-458e-9248-9fc551d37449",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "a326158e-ef83-481a-a7e2-05759d5caa8d",
          "evidence": "list/bullet: AB-729 provided robust and comparable HBsAg declines regardless of dose, dosing interval, HBeAg or DNA status. ~75% (26 of 34) patients had HBsAg levels <100 at some point. 50% (16 of 32) maintained HBsAg <1",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:07.079981+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 16,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 17,
      "type": "resolution",
      "title": "The slide uses a timeline-based process diagram to illustrate the clinical trial flow.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 52,
        "componentCount": 4,
        "textChars": 547,
        "nDataPoints": 4,
        "notes": "The slide uses a timeline-based process diagram to illustrate the clinical trial flow.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:54.749+00",
          "seconds": 6.218,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/17",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-17",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.63,
            "x": 0.31,
            "y": 0.11
          },
          "kind": "diagram",
          "text": "Clinical trial timeline showing randomization at week 24, treatment arms, and follow-up periods.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Timeline",
              "slug": "timeline",
              "status": "active",
              "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.749+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34d0c85d-2f60-44d3-b4b9-1ad53374db76",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.25,
            "x": 0.04,
            "y": 0.53
          },
          "kind": "paragraph",
          "text": "AB-729 in combination with ongoing NA therapy and short courses of Peg-IFNα-2a in cHBV patients. Enrollment complete. Additional preliminary data including IFN data expected in 1H '23",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.749+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d8d4ddb-befa-4bd3-b5b2-16f796eaf035",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.32,
            "w": 0.63,
            "x": 0.31,
            "y": 0.62
          },
          "kind": "paragraph",
          "text": "Multi-center, open-label Phase 2a. Primary objective: evaluate safety and tolerability... Preliminary results: First 15 patients... mean HBsAg decline was 1.51 log. After 24-weeks follow-up, patients may elect to stop NA therapy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.749+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b20d9516-3e23-4be0-834c-f5163b4134d3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.22,
            "x": 0.04,
            "y": 0.21
          },
          "kind": "title",
          "text": "AB-729-201: Phase 2a POC Clinical Trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.749+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f867856-48bf-420d-a282-aad945c46983",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "a12d5117-4adf-4ef6-b9d4-148a23c3d58e",
          "evidence": "The slide uses a horizontal axis with weeks to show the progression of a clinical trial.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 12:05:54.749+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 17,
          "frameworkName": "timeline"
        }
      ],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 18,
      "type": "resolution",
      "title": "The slide outlines a clinical trial design with two main arms involving AB-729, VTP-300, and optional Nivolumab.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 79,
        "componentCount": 7,
        "textChars": 773,
        "nDataPoints": 4,
        "notes": "The slide outlines a clinical trial design with two main arms involving AB-729, VTP-300, and optional Nivolumab.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:52.338+00",
          "seconds": 3.664,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/18",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-18",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.4,
            "w": 0.7,
            "x": 0.28,
            "y": 0.15
          },
          "kind": "diagram",
          "text": "Clinical trial timeline showing weeks 1-24, 26-48, and follow-up periods.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Timeline",
              "slug": "timeline",
              "status": "active",
              "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.338+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a026e117-a1e9-4626-a8bb-1385a4bfb144",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.15,
            "x": 0.04,
            "y": 0.46
          },
          "kind": "image",
          "text": "Vaccitech logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.338+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0ef9277e-bf7c-4b7f-b5e9-bfa503e0fe75",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.15,
            "x": 0.04,
            "y": 0.9
          },
          "kind": "image",
          "text": "Arbutus Biopharma logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.338+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f17e2d2-59e4-4fd5-ab43-8a2079204d17",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.65,
            "x": 0.3,
            "y": 0.6
          },
          "kind": "paragraph",
          "text": "Primary objective: evaluate safety and reactogenicity of AB-729 followed by VTP-300 or placebo. At week 48 all participants who are eligible to discontinue NA therapy will be followed for 48-weeks. Expand the clinical trial to include an additional arm with nivolumab (Opdivo), and dose first patient in this arm in the first half of 2023. Full rights retained by the Companies of their respective product candidates and all costs split equally",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.338+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "00c4d725-08c3-4700-8607-6e52580cfa70",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.04,
            "y": 0.575
          },
          "kind": "paragraph",
          "text": "POC Phase 2a clinical trial evaluating AB-729 in combination with Vaccitech's immunotherapeutic, VTP-300, and a NA. Preliminary data expected in 2H '23",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.338+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "05c26afe-4dec-46b1-b509-593fa57bfc8b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.2,
            "x": 0.3,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "* awaiting regulatory approval",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.338+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a0681b0c-b51b-496b-9098-a8b9b30f52fa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.04,
            "y": 0.21
          },
          "kind": "title",
          "text": "AB-729-202: Phase 2a POC Clinical Trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.338+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f50341e7-d7df-46de-87a8-2b02eed1fb63",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "1e080998-4edc-4036-9385-133d7a2a689b",
          "evidence": "Visual representation of clinical trial phases over time.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 12:05:52.338+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 18,
          "frameworkName": "timeline"
        }
      ],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 19,
      "type": "appendix",
      "title": "The slide details a specific licensing deal, including financial terms and partner background.",
      "function": "cite_precedent",
      "rawType": "other",
      "block": null,
      "metadata": {
        "slideType": "other",
        "slideTypeCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43",
          "version": 1,
          "description": null
        },
        "function": "cite_precedent",
        "functionCanon": {
          "name": "Cite precedent",
          "slug": "cite_precedent",
          "status": "active",
          "canonId": "019de52d-142b-714b-86d4-58aad7b568ec",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 67,
        "componentCount": 6,
        "textChars": 535,
        "nDataPoints": 4,
        "notes": "The slide details a specific licensing deal, including financial terms and partner background.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:55.077+00",
          "seconds": 6.375,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/19",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-19",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.25,
            "x": 0.05,
            "y": 0.42
          },
          "kind": "image",
          "text": "QILU PHARMACEUTICAL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:55.077+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14d541d9-3b98-464f-8b50-0fd0a60d4e1a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.2,
            "x": 0.7,
            "y": 0.6
          },
          "kind": "image",
          "text": "China",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Map",
              "slug": "map",
              "status": "active",
              "canonId": "019de52c-fe4d-77bd-b0a4-d72d58b9e5a4",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "map",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:55.077+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "789ce7c5-7737-45d9-9542-4c932a2eaae8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.25,
            "x": 0.05,
            "y": 0.5
          },
          "kind": "paragraph",
          "text": "Exclusive Licensing* and Strategic Partnership. Develop, manufacture and commercialize AB-729 in mainland China, Hong Kong, Macau and Taiwan",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:55.077+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a1742d0-0d10-4d5d-af4b-8d5da2fe62cb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.3,
            "x": 0.38,
            "y": 0.65
          },
          "kind": "paragraph",
          "text": "Qilu Pharmaceutical: One of the leading pharmaceutical companies in China, provides development, manufacturing, and commercialization expertise to this partnership",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:55.077+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f47bc1c4-7236-4af3-828e-4a67f4ec32d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.6,
            "x": 0.35,
            "y": 0.2
          },
          "kind": "table",
          "text": "Deal economics for Arbutus: $40M Upfront payment; $15M Equity investment; Up to $245M Commercialization and milestone payments; Double-digit up to low twenties % Tiered royalties",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:55.077+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "940322bb-c590-48d2-8867-026e428292a4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "title",
          "text": "AB-729 Strategic Collaboration",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:55.077+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8a15254f-4bdb-45b2-9370-106327aec3b5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Table data",
            "slug": "table-data",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
            "version": 1,
            "bodyDocId": null,
            "description": "Tabular layouts of structured data.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "f7354edc-2ea5-44e4-8f46-aed0bb8f76ce",
          "evidence": "table/data: Deal economics for Arbutus: $40M Upfront payment; $15M Equity investment; Up to $245M Commercialization and milestone payments; Double-digit up to low twenties % Tiered royalties",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:20:06.989848+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 19,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 20,
      "type": "resolution",
      "title": "The slide uses a three-column layout to explain the scientific basis and benefits of the drug.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 5,
        "textChars": 672,
        "nDataPoints": 0,
        "notes": "The slide uses a three-column layout to explain the scientific basis and benefits of the drug.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:53.023+00",
          "seconds": 3.968,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/20",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-20",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.86,
            "x": 0.07,
            "y": 0.82
          },
          "kind": "callout",
          "text": "AB-101 is advancing into Phase 1 clinical trial in 1H 2023",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e41b16bd-e004-4981-8be9-aee773ba660c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.36,
            "y": 0.23
          },
          "kind": "list",
          "text": "Small-Molecule Inhibitor Approach: Allows controlled checkpoint blockade; Enables oral dosing; Designed to reduce systemic safety issues seen with Abs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "326fac99-6896-477e-a805-f706c617ad0a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.65,
            "y": 0.23
          },
          "kind": "list",
          "text": "AB-101: Blocks PD-L1/PD-1 interaction; Activates HBV-specific immune responses; Novel MOA identified; Demonstrates robust checkpoint mediated in vivo effect; Improves HBV-specific T- and B-cell responses.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "807d802c-ffb7-46ef-ab37-314de9782517",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.07,
            "y": 0.23
          },
          "kind": "list",
          "text": "Rationale: HBV immune tolerance is a critical driver of cHBV infection; PD-1:PD-L1 checkpoint axis plays a key role; PD-L1 expression upregulated; PD-1 upregulated; Inhibition associated with HBsAg loss.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a4db3ebe-5e9a-4536-8b8c-c171769afd3f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.86,
            "x": 0.07,
            "y": 0.06
          },
          "kind": "title",
          "text": "AB-101: Oral PD-L1 Inhibitor for HBV Immune Reactivation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.023+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a8cc004c-eac8-44e8-91b4-2b76909a7367",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "ce54379f-7896-4d37-81b2-c789a220c127",
          "evidence": "list/bullet: AB-101: Blocks PD-L1/PD-1 interaction; Activates HBV-specific immune responses; Novel MOA identified; Demonstrates robust checkpoint mediated in vivo effect; Improves HBV-specific T- and B-cell responses.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:07.07211+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 20,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 22,
          "from": 20,
          "loop": {
            "name": "53_jobs_to_be_done",
            "slug": "53-jobs-to-be-done",
            "status": "active",
            "bestFor": "Product innovation, market entry, competitive positioning",
            "canonId": "019dd956-7b6c-7594-b5b3-eecbe0ab48e8",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
            "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying",
            "familyLabel": null
          },
          "matchId": "660159c2-70d4-4fb9-adcd-06670ff0292c",
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-101 and AB-161, as potential solutions (p20-22).",
          "position": 1,
          "objective": "What are the key challenges in treating HBV?",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 03:25:42.249373+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 21,
      "type": "evidence",
      "title": "Includes IC50 value and IFN-y fold increase data from patient samples.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 46,
        "componentCount": 5,
        "textChars": 283,
        "nDataPoints": 2,
        "notes": "Includes IC50 value and IFN-y fold increase data from patient samples.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:52.277+00",
          "seconds": 2.74,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/21",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-21",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.86,
            "x": 0.07,
            "y": 0.18
          },
          "kind": "callout",
          "text": "AB-101 is highly potent with demonstrated activity against PD-L1 in cells from chronic HBV patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.277+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "59341d90-4d33-4460-9a37-d22428d39214",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.4,
            "x": 0.55,
            "y": 0.35
          },
          "kind": "chart",
          "text": "AB-101 reinvigorates HBV-specific cHBV patient T-cells",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.277+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f87221f2-6fd8-4ea1-a145-48c6e0e5d925",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.4,
            "x": 0.07,
            "y": 0.35
          },
          "kind": "chart",
          "text": "AB-101 reduces PD-L1 on the surface of human primary myeloid cells",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.277+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce90339f-6306-4bb1-a911-7a3d16407115",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.15,
            "x": 0.35,
            "y": 0.48
          },
          "kind": "metric",
          "text": "IC50 = 1.9 nM",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.277+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84e3f836-5ea9-47bd-89b0-6410460eaeb9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.8,
            "x": 0.07,
            "y": 0.05
          },
          "kind": "title",
          "text": "AB-101: Small-Molecule Oral PD-L1 Inhibitor for HBV",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.277+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8f64d58c-8392-4658-89ba-c3f76b4fb5be",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "403fd3a1-f37e-42e7-9504-c7a8a1bca350",
          "evidence": "chart/line: AB-101 reduces PD-L1 on the surface of human primary myeloid cells",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:20:07.155119+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 21,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "8a118b57-f7d0-4710-9399-b5384e823ce2",
          "evidence": "chart/bar-vertical: AB-101 reinvigorates HBV-specific cHBV patient T-cells",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:20:07.195669+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 21,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 22,
          "from": 20,
          "loop": {
            "name": "53_jobs_to_be_done",
            "slug": "53-jobs-to-be-done",
            "status": "active",
            "bestFor": "Product innovation, market entry, competitive positioning",
            "canonId": "019dd956-7b6c-7594-b5b3-eecbe0ab48e8",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
            "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying",
            "familyLabel": null
          },
          "matchId": "660159c2-70d4-4fb9-adcd-06670ff0292c",
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-101 and AB-161, as potential solutions (p20-22).",
          "position": 1,
          "objective": "What are the key challenges in treating HBV?",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 03:25:42.249373+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 22,
      "type": "resolution",
      "title": "The slide uses a three-column layout to highlight the core benefits of the product.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 48,
        "componentCount": 5,
        "textChars": 410,
        "nDataPoints": 0,
        "notes": "The slide uses a three-column layout to highlight the core benefits of the product.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:52.168+00",
          "seconds": 2.591,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/22",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-22",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.87,
            "x": 0.07,
            "y": 0.8
          },
          "kind": "callout",
          "text": "AB-161 is advancing into Phase 1 clinical trial in 1H 2023",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "935f2384-92dc-4c91-9794-54c803d63c02",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.66,
            "y": 0.26
          },
          "kind": "list",
          "text": "Convenience: Potential for an oral HBsAg reducing agent and all oral combination therapy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a1ff8bc-f9d8-40c2-bcb4-e9fb7a4de101",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "list",
          "text": "Safety: Next generation small molecule anticipated to circumvent non-clinical safety findings with first generation molecule",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "13c458ea-9ba6-4985-b433-40799770a660",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.36,
            "y": 0.26
          },
          "kind": "list",
          "text": "Novelty: Offers a novel mechanism of action to reduce HBsAg, other viral proteins and viral RNA",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b7742e35-f2d3-43a3-83f7-140cf9b47a23",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.07,
            "y": 0.06
          },
          "kind": "title",
          "text": "AB-161: Next Generation Oral RNA Destabilizer",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.168+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3cf2e992-2787-4a58-807e-2de82067f70a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "aee335de-f830-483d-9ee2-0cd83c89e8da",
          "evidence": "list/bullet: Safety: Next generation small molecule anticipated to circumvent non-clinical safety findings with first generation molecule",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:07.280063+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 22,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 22,
          "from": 20,
          "loop": {
            "name": "53_jobs_to_be_done",
            "slug": "53-jobs-to-be-done",
            "status": "active",
            "bestFor": "Product innovation, market entry, competitive positioning",
            "canonId": "019dd956-7b6c-7594-b5b3-eecbe0ab48e8",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
            "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying",
            "familyLabel": null
          },
          "matchId": "660159c2-70d4-4fb9-adcd-06670ff0292c",
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-101 and AB-161, as potential solutions (p20-22).",
          "position": 1,
          "objective": "What are the key challenges in treating HBV?",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 03:25:42.249373+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 23,
      "type": "evidence",
      "title": "Includes both longitudinal efficacy data (line chart) and pharmacokinetic data (bar charts) comparing plasma vs liver concentrations.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 7,
        "textChars": 545,
        "nDataPoints": 12,
        "notes": "Includes both longitudinal efficacy data (line chart) and pharmacokinetic data (bar charts) comparing plasma vs liver concentrations.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:52.524+00",
          "seconds": 2.92,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/23",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-23",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.4,
            "w": 0.25,
            "x": 0.7,
            "y": 0.45
          },
          "kind": "chart",
          "text": "Fraction Unbound Concentrations (C24h) [AB-161]free: liver",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "491d9343-2906-49b4-96a7-d5a1c421b5eb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.2,
            "x": 0.45,
            "y": 0.45
          },
          "kind": "chart",
          "text": "Fraction Unbound Concentrations (C24h) [AB-161]free: plasma",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e727b581-7d04-4e6f-98af-20c2626610cf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.3,
            "x": 0.07,
            "y": 0.45
          },
          "kind": "chart",
          "text": "AAV-HBV mouse AB-161 QD for 14 days",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7a89dea1-c0b6-4863-9587-0fcb932361e8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.7,
            "x": 0.07,
            "y": 0.18
          },
          "kind": "list",
          "text": "AB-161 effective as a once-daily dose in AAV-HBV mouse model (0.3, 1, 10, 30 mg/kg QD)\nDose-dependent reduction of HBsAg, also observed with BID dosing (0.3 and 1 mg/kg BID)\nHBsAg reduction achieved when fraction unbound C24h > EC90 in liver",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e2499f21-9e7a-4b9e-93ac-b53b08c63f63",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.3,
            "x": 0.15,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Data presented at Discovery on Target Conference, October 2022",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7bedff3d-5c9f-423a-8692-f25e971fe901",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.07,
            "y": 0.13
          },
          "kind": "title",
          "text": "Compound concentration in liver drives efficacy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "344933c6-6ad9-4e27-ab5f-15b7a35662f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.07,
            "y": 0.06
          },
          "kind": "title",
          "text": "AB-161 Reduces HBsAg in AAV-HBV Mouse Model",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "16fb63c7-a07e-41cd-8819-cf55f53df068",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "e07505b4-fdf0-416e-9ef3-2a49cb232aab",
          "evidence": "chart/bar-vertical: Fraction Unbound Concentrations (C24h) [AB-161]free: plasma",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:20:07.363872+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 23,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "0b4fdba6-cf9b-4266-9e83-00de851f4657",
          "evidence": "chart/bar-vertical: Fraction Unbound Concentrations (C24h) [AB-161]free: liver",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:20:07.405369+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 23,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 24,
      "type": "setup",
      "function": "establish_context",
      "rawType": "context",
      "block": null,
      "metadata": {
        "slideType": "context",
        "slideTypeCanon": {
          "name": "Context (pitchdeck)",
          "slug": "context",
          "status": "active",
          "canonId": "019de52d-1094-779e-9590-e4603e6a191c",
          "version": 1,
          "description": null
        },
        "function": "establish_context",
        "functionCanon": {
          "name": "Establish context",
          "slug": "establish_context",
          "status": "active",
          "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 70,
        "componentCount": 6,
        "textChars": 635,
        "nDataPoints": 3,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:57.082+00",
          "seconds": 7.462,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/24",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-24",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.5,
            "w": 0.22,
            "x": 0.51,
            "y": 0.22
          },
          "kind": "list",
          "text": "Treatments: Vaccines (Durability of effect uncertain, boosters required, limited efficacy); Therapies (Sub-optimal)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:57.082+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34a1e323-82ae-466c-ab4d-24dff0c8eda7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.22,
            "x": 0.27,
            "y": 0.22
          },
          "kind": "list",
          "text": "Population: ~6.9M deaths globally; In US: ~80M cases; 1M deaths (as of March 2022)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:57.082+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "64dfb458-77b8-48b1-bebe-8e31222cd6b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.22,
            "x": 0.03,
            "y": 0.22
          },
          "kind": "list",
          "text": "Cause & Symptoms: Coronavirus Infections, such as COVID-19 caused by SARS-CoV-2; Spreads through breathing out droplets; Older adults at higher risk; Virus continues to mutate.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:57.082+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "68677663-5c22-4d94-a699-ed554aeaadb2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.22,
            "x": 0.75,
            "y": 0.22
          },
          "kind": "list",
          "text": "Rationale: Pan-coronavirus focused; Address essential viral targets (nsp12, nsp5); Potential for combo therapy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:57.082+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "af039e95-8d8e-4ff2-adf8-552c399bd771",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.15,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "1 https://www.healthdata.org/special-analysis/estimation-excess-mortality-due-covid-19-and-scalars-reported-covid-19-deaths",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:57.082+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1c8fe5e5-e5e0-4d58-8005-e32ac3f8404b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.45,
            "x": 0.076,
            "y": 0.06
          },
          "kind": "title",
          "text": "Coronavirus Program Overview",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:57.082+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "01e2cb07-cbd7-40ee-98c5-1766e73b982d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "7a0b1633-5b78-423b-8a92-d21745c29754",
          "evidence": "list/bullet: Cause & Symptoms: Coronavirus Infections, such as COVID-19 caused by SARS-CoV-2; Spreads through breathing out droplets; Older adults at higher risk; Virus continues to mutate.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:07.48856+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 24,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 25,
      "type": "resolution",
      "title": "The slide maps the viral genome to specific drug targets and highlights partnerships with X-Chem and Proteros.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 61,
        "componentCount": 7,
        "textChars": 404,
        "nDataPoints": 0,
        "notes": "The slide maps the viral genome to specific drug targets and highlights partnerships with X-Chem and Proteros.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:53.074+00",
          "seconds": 3.441,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/25",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-25",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.2,
            "x": 0.03,
            "y": 0.55
          },
          "kind": "callout",
          "text": "nsp5 protease & nsp12 polymerase essential enzymes for replication",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.074+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a8d65ef9-bedd-40a0-b691-e2037d078780",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.6,
            "x": 0.076,
            "y": 0.25
          },
          "kind": "diagram",
          "text": "Viral genome map showing nsp1-16 and structural proteins",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Value chain",
              "slug": "value-chain",
              "status": "active",
              "canonId": "019de52d-048a-769c-aad6-4abdde7ef317",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "value-chain",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.074+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "775a279a-8a89-4023-82b2-c3c4e874db14",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.3,
            "x": 0.3,
            "y": 0.58
          },
          "kind": "image",
          "text": "Protein structure models for nsp5 and nsp12",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.074+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e219658c-00e4-45f0-abcb-a46f50510ef2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.3,
            "x": 0.65,
            "y": 0.7
          },
          "kind": "list",
          "text": "Arbutus Strategy: Pan-coronavirus focused, Advance Mpro clinical candidate AB-343",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.074+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c4fa0311-e023-4dd6-bc59-129f60cf06ee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.076,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "Leveraging our proven expertise and capabilities in antiviral drug discovery and development",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.074+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c373b7f2-8ade-41ba-a07c-c52efd891bd1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.28,
            "x": 0.7,
            "y": 0.2
          },
          "kind": "table",
          "text": "Collaboration details with X-Chem and Proteros",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.074+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "df1f9619-91f8-4db8-932e-81abae8b27a5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.25,
            "x": 0.076,
            "y": 0.06
          },
          "kind": "title",
          "text": "Coronavirus Strategy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:53.074+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "811103d2-f32e-4830-8e6b-09cd3bfb33a0",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 26,
      "type": "resolution",
      "title": "The slide highlights key therapeutic advantages of the candidate drug.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 56,
        "componentCount": 5,
        "textChars": 480,
        "nDataPoints": 1,
        "notes": "The slide highlights key therapeutic advantages of the candidate drug.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:52.65+00",
          "seconds": 2.885,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/26",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-26",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.07,
            "y": 0.8
          },
          "kind": "callout",
          "text": "AB-343 is currently in IND-enabling studies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.65+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d380b98-09d7-4d14-849b-bb0c7b63e636",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.37,
            "y": 0.26
          },
          "kind": "list",
          "text": "Safety: Highly selective for coronavirus Mpro vs human proteases, Clean cell toxicity profile, Off-target assessment results unremarkable",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.65+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1f49a109-4f81-4296-b3de-adfafbff6c75",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.67,
            "y": 0.26
          },
          "kind": "list",
          "text": "Convenience: Preclinical PK supports ritonavir-free dosing, No anticipated drug-drug interactions, Data supports combination strategy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.65+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94a336b2-1693-407b-9c1f-f7ecf3b3a8d2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.28,
            "x": 0.07,
            "y": 0.26
          },
          "kind": "list",
          "text": "Activity: Highly potent (IC50 < 8nM), Equipotent against all known COVID-19 variants, Robust activity against Mpro resistant variants",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.65+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aaec83bc-025d-4f16-953f-0f7c3370defb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.45,
            "x": 0.07,
            "y": 0.06
          },
          "kind": "title",
          "text": "AB-343: MPRO Coronavirus Candidate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.65+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f18132d7-54c1-430b-b950-d907e28ab342",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "fb62b143-f1ec-4544-9467-0e86fe7735a0",
          "evidence": "list/bullet: Safety: Highly selective for coronavirus Mpro vs human proteases, Clean cell toxicity profile, Off-target assessment results unremarkable",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:20:07.612178+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 26,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 27,
      "type": "resolution",
      "title": "The slide uses a table to present a timeline of clinical milestones.",
      "function": "plan_implementation",
      "rawType": "timeline",
      "block": null,
      "metadata": {
        "slideType": "timeline",
        "slideTypeCanon": {
          "name": "Timeline",
          "slug": "timeline",
          "status": "active",
          "canonId": "019de52d-0851-75eb-b758-ea2965e7739a",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 36,
        "componentCount": 4,
        "textChars": 240,
        "nDataPoints": 3,
        "notes": "The slide uses a table to present a timeline of clinical milestones.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:52.238+00",
          "seconds": 2.346,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/27",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-27",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.028,
            "w": 0.924,
            "x": 0.076,
            "y": 0.162
          },
          "kind": "paragraph",
          "text": "Cash balance* of $184M as of December 31, 2022, cash runway into Q4 2024; 2023 net cash burn of between $95 and $100M",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.238+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "03a231e5-c115-405c-922f-ad016143a49a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.35,
            "x": 0.083,
            "y": 0.85
          },
          "kind": "source-note",
          "text": "*Consists of cash, cash equivalents and marketable securities",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.238+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "85c04e9d-cc4b-4f35-aaca-d65601f72507",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.85,
            "x": 0.076,
            "y": 0.25
          },
          "kind": "table",
          "text": "Milestone and Anticipated Timing 2023 table",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.238+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "07ca8901-ae9b-4442-92fd-bcb52d9ff742",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.074,
            "w": 0.364,
            "x": 0.076,
            "y": 0.056
          },
          "kind": "title",
          "text": "2023 Key Milestones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:52.238+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1e44e182-f289-44bb-902c-77d8719e57a0",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Table data",
            "slug": "table-data",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
            "version": 1,
            "bodyDocId": null,
            "description": "Tabular layouts of structured data.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "cdc8915b-bd88-402e-a33c-6c5832dec8b3",
          "evidence": "table/data: Milestone and Anticipated Timing 2023 table",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:20:07.692674+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 27,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 28,
      "type": "setup",
      "function": "state_next_steps",
      "rawType": "closing_ask",
      "block": null,
      "metadata": {
        "slideType": "closing_ask",
        "slideTypeCanon": {
          "name": "Closing ask",
          "slug": "closing_ask",
          "status": "active",
          "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c",
          "version": 1,
          "description": null
        },
        "function": "state_next_steps",
        "functionCanon": {
          "name": "State next steps",
          "slug": "state_next_steps",
          "status": "active",
          "canonId": "019de52d-14ca-70ac-b534-971f458cdf29",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 18,
        "componentCount": 4,
        "textChars": 39,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:05:54.476+00",
          "seconds": 4.558,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de074-7472-72bc-8651-e49cc0d0319c/28",
        "deck": "/decks/019de074-7472-72bc-8651-e49cc0d0319c",
        "deckAnchor": "/decks/019de074-7472-72bc-8651-e49cc0d0319c#slide-28",
        "deckJson": "/decks/019de074-7472-72bc-8651-e49cc0d0319c.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.015,
            "w": 0.188,
            "x": 0.802,
            "y": 0.955
          },
          "kind": "disclaimer",
          "text": "© 2023 Arbutus Biopharma, Inc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a9aaeaae-dfbb-4d5c-8c44-60187655eca2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.035,
            "w": 0.128,
            "x": 0.01,
            "y": 0.9
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "19fdf8d4-86c9-440b-9731-e866a3fa6b8a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.613,
            "w": 0.329,
            "x": 0.571,
            "y": 0.177
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cbd465c9-1942-4c98-9bf1-88109c0525bc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.29,
            "x": 0.058,
            "y": 0.448
          },
          "kind": "title",
          "text": "Thank You",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:05:54.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e3ab027-07c8-4acd-b591-e15a9131fa23",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Storytelling: the closing ask",
            "slug": "closing-ask",
            "status": "active",
            "bestFor": null,
            "canonId": "019df269-24e0-70ab-8dd9-983832c1c665",
            "version": 1,
            "bodyDocId": "019df269-24bc-7554-b88d-245127606b8d",
            "description": "The single most important slide in the deck — after the cover. The final",
            "familyLabel": "narrative-block",
            "categoryName": "Narrative & Transformation",
            "categorySlug": "narrative-transformation"
          },
          "agent": "storyteller",
          "layer": "slide",
          "agents": [
            "storyteller"
          ],
          "matchId": "9ad80852-4f11-4718-a47b-ff4af1eda049",
          "evidence": "title/headline: Thank You",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:20:07.773096+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 28,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Solution",
          "beatId": "8e825e5a-e303-4698-98f8-f2a022a4a5c6",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Solution (Provide relief)",
            "slug": "problem-agitate-solution-solution-provide-relief",
            "status": "active",
            "canonId": "019dd9b8-0fee-73e9-9ae5-799c7f3895cd",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28).",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 28,
          "arc": {
            "name": "Problem-Agitate-Solution",
            "slug": "problem-agitate-solution",
            "status": "active",
            "bestFor": "Sales pitches, urgency-driven, competitive displacement",
            "canonId": "019dd956-5ec6-70f9-9fd8-fdbaaff39acf",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem (Identify pain) -> Agitate (Make it worse) -> Solution (Provide relief)",
            "description": null,
            "familyLabel": null
          },
          "from": 17,
          "name": "Impact & Next Steps",
          "beatId": "f38a537d-5a41-47d5-be5b-904ed8c0f42a",
          "matchId": "c167fe8c-286f-4f59-8661-198c6c6fa19d",
          "beatType": {
            "name": "Impact & Next Steps",
            "slug": "consultants-gambit-impact-next-steps",
            "status": "active",
            "canonId": "019dd9b8-0849-7728-9ee9-fd1609c4c655",
            "version": 1,
            "description": null
          },
          "evidence": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28).",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Resolution",
            "slug": "resolution",
            "status": "active",
            "canonId": "019dd9b8-045d-703b-8dd7-e92aba3ba91b",
            "version": 1,
            "description": "How the deck ends. Required in 19/20 arcs. The exception (Sparkline) ends with new bliss which is functionally a resolution."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    }
  ],
  "arcBeats": [
    {
      "from": 6,
      "to": 7,
      "label": "Problem",
      "description": "The document identifies HBV as a significant unmet medical need (p6-7)."
    },
    {
      "from": 7,
      "to": 7,
      "label": "Complication",
      "description": "The document highlights the limitations of current treatments (p7)."
    },
    {
      "from": 8,
      "to": 28,
      "label": "Solution",
      "description": "The document presents Arbutus Biopharma's pipeline, including AB-729, AB-101, and AB-161, as a potential solution (p8-28)."
    },
    {
      "from": 10,
      "to": 14,
      "label": "Evidence & Proof",
      "description": "The document presents data and results from clinical trials, including AB-729-001 (p10-14)."
    },
    {
      "from": 17,
      "to": 28,
      "label": "Impact & Next Steps",
      "description": "The document outlines the next steps for AB-729 and other pipeline programs (p17-28)."
    }
  ],
  "loops": [
    {
      "from": 7,
      "to": 8,
      "label": "Cost Of Inaction",
      "description": "What is the cost of not addressing HBV?"
    },
    {
      "from": 20,
      "to": 22,
      "label": "Jobs To Be Done",
      "description": "What are the key challenges in treating HBV?"
    }
  ]
}